Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Gasco

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Pharmaceutics|February 13, 2001
Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxelA Miglietta, R Cavalli, C Bocca, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 15, 1998
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexesS Morel, E Terreno, E Ugazio, et al.
The Journal of Pharmacy and Pharmacology|October 25, 2000
Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to ratsV Podio, G P Zara, M Carazzonet, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
Microemulsions as topical delivery vehicles: ocular administration of timololM R Gasco, M Gallarate, M Trotta, et al.
Pharmacological Research|September 16, 2000
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsA Fundarò, R Cavalli, A Bargoni, et al.
Anticancer Research|January 11, 2000
Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid deliveryC Pellizzaro, D Coradini, S Morel, et al.
Pharmacological Research|November 4, 2000
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic studyR Cavalli, G P Zara, O Caputo, et al.
Pharmaceutical Research|June 10, 1998
Solid lipid nanoparticles in lymph and plasma after duodenal administration to ratsA Bargoni, R Cavalli, O Caputo, et al.
Pharmacological Research|June 8, 2001
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distributionA Bargoni, R Cavalli, G P Zara, et al.
Pharmacological Research|September 10, 1999
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)G P Zara, R Cavalli, A Fundarò, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Pharmaceutics|February 13, 2001
Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxelA Miglietta, R Cavalli, C Bocca, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 15, 1998
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexesS Morel, E Terreno, E Ugazio, et al.
The Journal of Pharmacy and Pharmacology|October 25, 2000
Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to ratsV Podio, G P Zara, M Carazzonet, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
Microemulsions as topical delivery vehicles: ocular administration of timololM R Gasco, M Gallarate, M Trotta, et al.
Pharmacological Research|September 16, 2000
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsA Fundarò, R Cavalli, A Bargoni, et al.
Anticancer Research|January 11, 2000
Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid deliveryC Pellizzaro, D Coradini, S Morel, et al.
Pharmacological Research|November 4, 2000
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic studyR Cavalli, G P Zara, O Caputo, et al.
Pharmaceutical Research|June 10, 1998
Solid lipid nanoparticles in lymph and plasma after duodenal administration to ratsA Bargoni, R Cavalli, O Caputo, et al.
Pharmacological Research|June 8, 2001
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distributionA Bargoni, R Cavalli, G P Zara, et al.
Pharmacological Research|September 10, 1999
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)G P Zara, R Cavalli, A Fundarò, et al.
Pageof 7